Antianginal Effects of YM430, a Novel Calcium Entry-Blocking and -Adrenoceptor-Blocking Agent in Several Experimental Angina Models - a double-blind placebo-controlled crossover trial

By Shibasaki K.   Arai Y.   Uchida W.   Okazaki T.   Asano M.   Takenaka T.  

General Pharmacology, Vol. 29, Iss. 4, 1997-10 ,pp. : 545-550

Elsevier

Access to resources Recommend Favorite

A Randomized, Double-blind, Placebo-controlled Trial of a New Weight-reducing Agent of Natural Origin

By Thom E  

The Journal of International Medical Research, Vol. 28, Iss. 5, 2000-09 ,pp. : 229-233

Field House Publishing

Access to resources Recommend Favorite

Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

By  

Current Medicinal Chemistry, Vol. 20, Iss. 10, 2013-04 ,pp. : 1323-1331

Bentham Science Publishers

Access to resources Recommend Favorite

Flutamide in unresectable pancreatic adenocarcinoma: A randomized, double-blind, placebo-controlled trial

By Negi Sanjay   Agarwal Anil   Chaudhary Adarsh  

Investigational New Drugs, Vol. 24, Iss. 3, 2006-05 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite

A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression

By Hantsoo Liisa   Ward-O’Brien Deborah   Czarkowski Kathryn   Gueorguieva Ralitza   Price Lawrence   Epperson C.  

Psychopharmacology, Vol. 231, Iss. 5, 2014-03 ,pp. : 939-948

Springer Publishing Company

Access to resources Recommend Favorite